Proficio Capital Partners LLC Repligen Corp Transaction History

Proficio Capital Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$123.41 - $160.92 $2.63 Million - $3.43 Million	21,303 New	21,303 $3.07 Million
Q1 2023 Apr 19, 2023	BUY	$154.26 - $198.1 $15.1 Million - $19.3 Million	97,649 New	97,649 $16.4 Million
Q3 2019 Nov 13, 2019	SELL	$76.65 - $95.51 $3,295 - $4,106	-43 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $921 - $1,461	17 Added 65.38%	43 $4,000
Q1 2019 May 13, 2019	BUY	$49.45 - $62.8 $1,285 - $1,632	26 New	26 $2,000

477

54.9M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.66B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.